Blog

Fulvic acid content in the food supply has declined significantly over the past 70 years. The organic matter in agricultural topsoil, from which fulvic acid is derived, has been depleted by intensive farming, synthetic fertilisers, and monoculture agriculture. The result is that women today obtain meaningfully less fulvic acid from vegetables and whole foods than their grandmothers did from the same foods grown in the same regions.

This matters because fulvic acid plays a specific role in three health areas that disproportionately affect women: iron and mineral bioavailability (relevant to the 30% of women who are iron deficient), cellular energy production (relevant to the disproportionate burden of fatigue and fibromyalgia in women), and neuroprotection against tau protein aggregation (relevant to the significantly higher lifetime Alzheimer's risk in women). The compound is not a trend, it is a genuinely useful micronutrient whose depletion from the food supply has measurable health consequences.

What fulvic acid is and why modern women are deficient in it

Fulvic acid is a low-molecular-weight organic acid produced by the microbial decomposition of plant matter in soil. It is found in healthy, organically rich soil, in certain bodies of water, and, in its highest concentration, in shilajit resin formed from millions of years of compressed plant decomposition in high-altitude rock formations.

Its key biological property is membrane permeability, at under 1,000 daltons molecular weight, fulvic acid is small enough to cross cell membranes directly. This distinguishes it from larger compounds like humic acid, which stays in the gut, and from most minerals in free ionic form, which depend on active transport mechanisms with variable efficiency. Fulvic acid gets inside cells, and it takes minerals with it.

Fulvic acid and iron, the most important benefit for women

Iron deficiency is the most common nutritional deficiency in the world, and women carry the overwhelming burden of it. Menstruation, pregnancy, and breastfeeding all create significant iron demands that the diet frequently cannot meet. The World Health Organization estimates that 30% of women of reproductive age globally are anaemic, with iron deficiency as the primary cause. In India and South Asia the figure is considerably higher, affecting approximately 50% of women in some age groups.

Standard iron supplementation is effective in principle but poorly tolerated in practice. Ferrous sulphate, the most common prescribed iron form, has approximately 20% bioavailability, with the remaining 80% passing through the gut unabsorbed. That unabsorbed iron oxidises in the colon, causing the constipation, nausea, and abdominal discomfort that leads a significant proportion of women to stop taking iron supplements before their levels are restored.

Fulvic acid addresses both the efficacy and tolerability problems simultaneously. When fulvic acid chelates iron, binding to it via its multiple carboxyl and hydroxyl functional groups, it forms a fulvic acid-iron complex that is more stable in the acidic stomach environment, more readily absorbed through the intestinal wall, and less likely to cause oxidative irritation in the colon. A 2010 study in the Journal of Ethnopharmacology specifically examining women with iron-deficiency anaemia found significantly greater haemoglobin improvement and faster ferritin recovery in women taking fulvic acid alongside iron, compared to those taking iron alone. Fewer gastrointestinal side effects were also reported in the fulvic acid group.

The practical implication is important: for women who struggle with iron supplement side effects, fulvic acid taken alongside iron may allow a smaller iron dose to achieve the same haemoglobin improvement, reducing the gut burden while maintaining efficacy. Women with confirmed iron deficiency should discuss this with their doctor rather than self-adjusting supplementation, but the mechanism is well-supported.

Energy and fatigue, the mitochondrial mechanism

Fatigue is one of the most commonly reported health complaints among women, and one of the most poorly addressed by conventional medicine when no specific pathology is identified. Conditions characterised primarily by fatigue, fibromyalgia, chronic fatigue syndrome, hypothyroidism, and iron-deficiency anaemia, disproportionately affect women. The mitochondrial energy mechanism of fulvic acid is relevant across all of these.

Mitochondria produce cellular energy (ATP) through the electron transport chain, a series of protein complexes through which electrons are passed, generating the proton gradient that drives ATP synthesis. Fulvic acid, due to its quinone and semiquinone functional groups, acts as an electron shuttle in this chain, facilitating more efficient electron transfer and increasing ATP output per mitochondrion. This is a fundamentally different mechanism from stimulants (which activate the nervous system) or iron supplements (which address one upstream cause of fatigue). It improves the cellular energy machinery directly.

A 2009 study documented fulvic acid's role in CoQ10 stabilisation and mitochondrial function enhancement. CoQ10 is the primary electron carrier in the mitochondrial electron transport chain, it accepts electrons from complexes I and II and passes them to complex III. Fulvic acid's stabilisation of CoQ10 and its own electron-carrier activity work synergistically to improve overall chain efficiency. Women who are deficient in CoQ10, a condition that increases with age and with statin use, may find fulvic acid particularly beneficial for the energy component specifically.

The energy improvement from fulvic acid is typically gradual, noticeable within 2–4 weeks of consistent use, rather than immediate. This is consistent with a mechanism that improves cellular infrastructure rather than providing a stimulant-type effect. Women expecting immediate energy like caffeine provides are likely to be disappointed; women giving it a 6–8 week assessment typically report a more sustained, foundational shift in energy levels.

Cognitive protection, fulvic acid and Alzheimer's risk in women

Women develop Alzheimer's disease at higher rates than men, not solely because women live longer, but because there appears to be a sex-specific biological vulnerability, likely related to oestrogen's neuroprotective effects declining at menopause. Women account for approximately two-thirds of all Alzheimer's cases globally. This is the health statistic that most directly elevates fulvic acid's relevance to women beyond the general supplement market.

Alzheimer's disease is characterised by two pathological hallmarks: amyloid-beta plaques and neurofibrillary tangles formed by hyperphosphorylated tau protein. Current pharmaceutical approaches target both pathways. Fulvic acid has documented activity specifically on the tau pathway, a 2011 paper by Cornejo and Bhaskara in the Journal of Alzheimer's Disease found that fulvic acid inhibited the self-aggregation of tau protein in vitro at physiologically relevant concentrations. The same study found it disrupted pre-formed tau aggregates.

This is in vitro research, cell culture, not human clinical trial, and must be contextualised accordingly. Many compounds show tau inhibition in vitro that do not survive translation to human studies. The finding establishes a plausible mechanism and a scientifically credible research direction, not a treatment claim. What it supports is the rational inference that consistent fulvic acid intake, combined with its mitochondrial energy support (mitochondrial dysfunction is an early feature of Alzheimer's pathology), may contribute to neuroprotective outcomes, a modest but reasonable inference for a compound with an otherwise safe profile.

Bone density and mineral absorption in perimenopause

Bone density loss accelerates in the years surrounding menopause, driven by the decline in oestrogen, which normally suppresses osteoclast (bone-resorbing cell) activity. Women can lose 2–3% of bone density per year in the peri and early post-menopausal period, the foundation of the osteoporosis risk that affects one in three women over 50.

The standard nutritional response is calcium and vitamin D supplementation. Both are genuinely necessary, but the effectiveness of calcium supplementation in particular is limited by bioavailability. Calcium carbonate, the most common form, has approximately 22% bioavailability in the best conditions, and absorption falls further with age as gastric acid production declines. Calcium citrate improves this modestly. Fulvic acid-chelated calcium, however, is absorbed significantly more efficiently through the active transport mechanism described earlier.

Shilajit's trace mineral profile, which includes calcium, magnesium, phosphorus, manganese, and silicon alongside the fulvic acid that makes them bioavailable, provides a matrix of bone-relevant minerals in their most absorbable form. This is not a replacement for calcium supplementation when bone density is already declining, but it is a meaningful addition to a bone health protocol for women approaching perimenopause who want to maximise the efficiency of the minerals they are already taking.

Magnesium deserves specific mention in the bone context. Magnesium is required for vitamin D activation; without adequate magnesium, vitamin D supplementation is significantly less effective. Women who take vitamin D (as most should during winter months) and are magnesium deficient are not getting the full benefit of their vitamin D. Fulvic acid-chelated magnesium from shilajit improves the bioavailability of this frequently deficient mineral and may improve the downstream effectiveness of vitamin D already being taken.

How to get fulvic acid, food, supplements, and shilajit

From food. Organically farmed vegetables grown in mineral-rich soil contain modest amounts of fulvic acid, particularly root vegetables, which grow in direct contact with soil. The more organic matter in the soil, the higher the fulvic acid content of what grows in it. In practice, consistently eating organic produce from small farms using traditional growing methods is the dietary approach most likely to maintain meaningful dietary fulvic acid intake. Conventionally farmed produce from depleted soils provides very little.

From standalone fulvic acid supplements. Extracted from leonardite (a form of lignite) or peat, these provide the fulvic acid compound without the mineral matrix. Useful for people who want the membrane permeability and mitochondrial benefits specifically, or who are taking separate targeted mineral supplementation. Typically cheaper than shilajit and available in liquid and capsule forms.

From shilajit resin. The most concentrated and matrix-complete source, fulvic acid pre-complexed with 80+ trace minerals, as it exists naturally. The advantage over isolated fulvic acid supplements is that the minerals arrive already bound to the carrier, ready for cellular transport. The iron, calcium, magnesium, and other bone and blood-relevant minerals come with the absorption mechanism built in. For the specific female health applications discussed in this article, iron absorption, bone minerals, and comprehensive mitochondrial support, the whole-matrix shilajit resin is the more relevant form.

The critical specification when choosing shilajit is fulvic acid percentage, which should be listed on the label with third-party verification. 60–80%+ fulvic acid content is appropriate for therapeutic use. Heavy metal testing is non-negotiable, raw shilajit contains naturally occurring heavy metals that must be removed by the purification process; a supplier who cannot provide a certificate of analysis for heavy metals should not be trusted regardless of other claims.

Frequently asked questions

The bottom line

Fulvic acid's relevance to women is not coincidental; three of its best-supported mechanisms map directly onto three health areas where women carry a disproportionate burden: iron deficiency, fatigue, and Alzheimer's risk. The depletion of fulvic acid from the modern food supply makes the case for supplementation stronger than it was a generation ago. Shilajit resin, the most concentrated natural source, delivers fulvic acid pre-complexed with the mineral matrix that makes its absorption and transport mechanisms most effective. Start with 300mg/day of a verified high-fulvic shilajit resin, give it three months, and do not use during pregnancy or breastfeeding.